Partners

Healthcare Professionals

Atrantil for Healthcare Professionals

A Gastroenterologist-Developed, Polyphenol-Powered Approach for Bloating, Methane-Associated Digestive Imbalance, Dysbiosis, and Gut Barrier Support

“Atrantil has shown significant and drastic improvement in my patients’ symptoms, especially abdominal bloating.”

— Tony Macaluso, MD, FACS, FASCRS

Atrantil was developed by Dr. Ken Brown after years of seeing patients struggling with:

  • bloating
  • abdominal distention
  • constipation
  • gas pressure
  • diarrhea-associated imbalance
  • and methane-associated digestive symptoms

that often did not respond to:

  • probiotics
  • fiber
  • antibiotics
  • restrictive diets
  • or conventional approaches.

The goal was never simply symptom masking. The goal was understanding why the bloating was happening in the first place.

Atrantil products are designed to work at the level of:

  • microbial fermentation
  • methane production
  • digestive flow
  • altered microbiome activity
  • gut barrier integrity
  • and microbial balance within the digestive tract.

Information on this page is intended for healthcare professionals practicing in the United States.

Two Products. One Mechanism-First Philosophy.

We currently offer two practitioner-focused products, that are:

  • polyphenol-powered
  • clinically studied
  • gastroenterologist developed
  • and designed to address mechanisms associated with digestive symptoms rather than simply masking them.
Atrantil® Atrantil PRO
Methane-associated bloating Broader microbiome restoration
Small intestine focused Colon + barrier support
Fermentation + methane pathways Dysbiosis + gut barrier integrity
First-line digestive support More complex microbiome cases
Gas pressure + constipation Post-antibiotic + inflammatory support

Atrantil®

Designed for:

  • methane-associated bloating
  • constipation-associated distention
  • excessive microbial gas production
  • SIBO/IMO-adjacent presentations
  • altered digestive flow
  • abdominal discomfort.

Atrantil focuses primarily on the small intestine and duodenal environment.

Atrantil PRO

Atrantil PRO combines the Atrantil polyphenol blend with three soil-based spore biotics selected specifically to work synergistically with the polyphenols.

Designed for patients with:

  • dysbiosis
  • broader microbial imbalance
  • post-antibiotic digestive dysfunction
  • diarrhea-associated imbalance
  • stubborn gut dysfunction
  • gut barrier dysfunction (“leaky gut”)
  • fatigue associated with digestive dysfunction.

Atrantil PRO expands support beyond methane-associated bloating into broader microbiome restoration and intestinal barrier support.

When to Recommend Atrantil

Atrantil may be appropriate for patients experiencing:

  • chronic or occasional bloating
  • abdominal distention
  • constipation-associated gas buildup
  • excessive belching or trapped gas
  • methane-associated digestive symptoms
  • suspected IMO/SIBO-adjacent presentations
  • abdominal discomfort with altered bowel habits
  • difficult-to-treat bloating.

Atrantil is often used:

  • as a first-line non-antibiotic approach
  • or in patients who have not responded well to conventional therapies.

When to Escalate to Atrantil PRO

Atrantil PRO may be more appropriate for patients experiencing:

  • persistent dysbiosis
  • post-antibiotic digestive dysfunction
  • broader microbiome instability
  • stubborn gut barrier dysfunction
  • diarrhea-associated imbalance
  • fatigue associated with digestive dysfunction
  • inflammatory digestive patterns
  • patients requiring broader microbiome restoration support.

The original Atrantil primarily focuses on:

  • methane-associated fermentation
  • hydrogen pathways
  • digestive flow
  • and excessive microbial gas production.

Atrantil PRO expands that support deeper into:

  • microbiome diversity
  • butyrate production
  • gut barrier integrity
  • inflammatory signaling
  • and broader microbial balance.

How Atrantil Works

Atrantil is a patented combination of three natural botanical extracts designed to work together within the small intestine.The focus is mechanism-first:

  • hydrogen-associated fermentation
  • methane production
  • altered digestive flow
  • microbial imbalance
  • and excessive microbial gas production.

Step 1: Slow Motility and Extend Contact Time

The first botanical, peppermint leaf, acts as a natural antispasmodic.¹²

Research suggests peppermint may help:

  • support digestive comfort
  • reduce spasmodic contractile activity
  • relax smooth muscle
  • and slow excessive motility within the duodenum.

This allows the other ingredients more time to interact within the gut lumen.

Related Reading:

  • Peppermint and Digestive Flow
  • Why Motility Matters
  • Understanding Digestive Flow

Step 2: Bind Hydrogen and Disrupt Methane-Associated Archaea

The second botanical, quebracho colorado, contains tannin-rich polyphenols called proanthocyanidins.¹³

Research suggests these polyphenols may:

  • bind free hydrogen within the small intestine
  • interfere with hydrogen-associated fermentation pathways
  • and help fragment the cell wall of methane-associated archaea bacteria.

In simple terms?
Atrantil targets the environment methane-associated microbes depend on.This became one of the foundational mechanisms behind the formulation.

Related Reading:

  • Quebracho: The South American Polyphenol Powerhouse
  • Tannins and Gut Health
  • What Causes Methane Bloating?
  • What Is IMO?

Podcast Cross Reference: Dr. Kenneth Brown discusses methane, fermentation, and microbial gas production in more detail on The Gut Check Project podcast. Available on: Spotify YouTube Apple Podcasts

Step 3: Support Microbial Balance and Methane Reduction

The third botanical, horse chestnut seed extract, contains aescin, a membrane-active saponin complex.¹⁴

Research suggests aescin may:

  • interact with microbial membranes
  • influence methane-associated microbial activity
  • support microbial balance
  • and interfere with methanogenesis pathways.¹⁴⁻¹⁶

Together, the three ingredients were selected for different jobs:

  • peppermint for motility and contact time
  • quebracho for hydrogen-associated fermentation pathways
  • horse chestnut for methane-associated microbial interactions.

Three ingredients. Three different jobs. One coordinated formula.

What Atrantil PRO Adds

On top of the original Atrantil mechanism, the added soil-based spore biotics in Atrantil PRO have been studied for their ability to:

  • support butyrate production
  • reinforce gut barrier integrity
  • support microbial diversity
  • support Akkermansia muciniphila
  • reduce inflammatory signaling
  • influence LPS-associated inflammation
  • and help disrupt bacterial biofilms associated with dysbiosis.

Why Butyrate Matters

Butyrate is one of the primary fuel sources for colon cells.It plays an important role in:

  • gut barrier integrity
  • microbial balance
  • immune regulation
  • and inflammatory signaling.

Low butyrate production has been associated with:

  • dysbiosis
  • inflammatory bowel conditions
  • altered permeability
  • and broader microbiome instability.

The spore biotics in Atrantil PRO help support microbial environments associated with healthier butyrate production.

Supporting Akkermansia muciniphila

One of the key microbial targets in Atrantil PRO is: Akkermansia muciniphila.

This bacterium has become increasingly studied for its relationship to:

  • gut barrier integrity
  • metabolic health
  • microbiome diversity
  • and inflammatory regulation.

Research suggests healthier levels of Akkermansia may be associated with improved intestinal barrier function and broader digestive resilience.

The Polyphenol + Spore Biotic Relationship

This is where the formulation becomes especially interesting. Atrantil’s tannin-rich polyphenols are broken down into smaller phenolic compounds through enzymes produced by the spore biotics, including tannase activity. Those smaller phenolic compounds may then act as prebiotic fuel for beneficial microbes deeper in the colon. In simple terms, spore biotics help unlock additional downstream activity in polyphenols. At the same time:

  • The polyphenols influence microbial balance
  • while the spore biotics support colonization and butyrate production.

The goal is not simply to add bacteria. The goal is to create conditions that support a healthier, more diverse microbiome over time.

Additional Mechanisms Behind Atrantil PRO

Gut Barrier Support

Research suggests the spore strains may help reinforce intestinal barrier integrity and reduce permeability associated with “leaky gut.”This includes support for:

  • tight junction integrity
  • mucosal protection
  • and barrier resilience.

LPS + Inflammatory Signaling

Lipopolysaccharide (LPS) is an endotoxin associated with inflammatory signaling and microbiome imbalance.Research suggests spore biotics may help:

  • reduce LPS-associated signaling
  • downregulate inflammatory pathways
  • and support healthier immune regulation.

NRF2 + Antioxidant Support

The combination of polyphenols and spore biotics may also support NRF2 activation, one of the body’s major antioxidant regulatory pathways.

In simple terms?

This helps support the body’s natural antioxidant defense systems and may help reduce oxidative stress within the gut environment.

Biofilm Disruption

One of the biggest challenges in dysbiosis is bacterial biofilm formation.Biofilms help protect unwanted microbes from:

  • immune responses
  • antimicrobial therapies
  • and environmental disruption.

Research suggests tannin-rich polyphenols may help interfere with biofilm structure and microbial adhesion patterns.

Recommended Dosing

Atrantil® + Atrantil PRO

Suggested dosing:

  • Two capsules
  • Up to three times daily
  • With or without food

Time to relief varies depending on:

  • microbial load
  • digestive motility
  • symptom severity
  • and individual microbiome patterns.

In clinical evaluations:

  • some patients reported symptom relief within days
  • many reported improvement within the first 10 days.⁹⁻¹¹

Optimal results require consistency with dosing.

Related Reading:

What Patients May Experience

For many patients, Atrantil provides progressive improvement during the first several weeks.

Some patients may temporarily experience:

  • mild digestive shifts
  • transient bloating fluctuations
  • changes in bowel patterns
  • or short-lived “die-off” type symptoms.

These symptoms are hypothesized to reflect microbial shifts and endotoxin exposure as microbial balance changes.

Possible short-lived symptoms may include:

  • foggy head
  • mild headache
  • temporary loose stool
  • muscle aches
  • fatigue.

Atrantil can be taken with or without food, although mild stomach discomfort may occur on an empty stomach.

Safety Profile

Atrantil’s ingredients primarily act within the gut lumen with minimal systemic absorption due to their large macromolecular structure. The side-effect profile is considered minimal.

Atrantil has not been evaluated in:

  • pregnancy
  • breastfeeding
  • pediatric populations.

As with any supplement, patients with complex medical conditions should consult their healthcare provider.

Clinical Evidence

Atrantil has been evaluated in multiple published clinical studies.

Northwestern University Feinberg School of Medicine Study

An independent investigator-initiated study reported:

  • 56% adequate relief across seven categories of GI symptoms
  • broad inclusion criteria
  • and real-world patient representation.⁹

Principal Investigator:Darren Brenner, MD, FACG, AGAF

View Clinical Trial

Double-Blind Placebo-Controlled Study

Published in the Journal of Gastroenterology and Hepatology Research (2015).The study reported:

  • greater than 88% improvement in bloating and abdominal symptoms
  • significant improvements in constipation and abdominal discomfort.¹⁰
View Clinical Trial

Open-Label Clinical Evaluation

Published in the World Journal of Gastrointestinal Pharmacology and Therapeutics (2016).Approximately 80% of participants reported improvement in:

  • bloating
  • constipation
  • abdominal discomfort.¹¹

Importantly, these participants had previously failed multiple therapies.

View Clinical Trial

Get Introductory Wholesale Pricing

If you are interested in offering patients a:

  • non-antibiotic
  • mechanism-first
  • polyphenol-powered
  • clinically evaluated

approach for bloating, methane-associated symptoms, and broader microbiome restoration, we would be happy to send you additional information and set you up with introductory wholesale pricing.

Healthcare Concierge:
Email: Dacia@kbsresearch.com

Become a Wholesaler